In an episode of the Bloomberg Balance of Power podcast titled “Responding to the Omicron Variant,” Rutgers Global Health Institute director Richard Marlink talks about vaccination uptake, protecting older people, mask mandates, frustrations with government officials, travel bans, and holiday gatherings.
University experts in infectious disease, epidemiology, pediatrics, and global health share insights related to Omicron, which the World Health Organization has labeled a variant of concern.
Rutgers faculty member Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses questions about the vaccine rollout for this age group.
The clinics offered a convenient location for New Brunswick residents and underscored the market’s mission to connect food and health. The initiative was organized in partnership with Rutgers Global Health Institute, Visiting Nurse Association of Central Jersey, New Jersey Black Women Physicians Association, and New Brunswick Tomorrow.
Emanuel Garcia, who owns a Mexican store in the city’s Esperanza neighborhood, has seen his business take a huge hit during the COVID-19 pandemic. A Rutgers Global Health Institute program helped him stay open and continue serving the community’s needs safely.
As the COVID-19 Delta variant spreads and infection rates surge in New Jersey, Rutgers faculty and staff have been helping to improve vaccination rates in hard-hit areas.
Rutgers helped launch the Community Connectors campaign, which involves city residents who recruit local barbers to espouse the merits and accessibility of getting vaccinated.
In episode 9 of On the Pandemic, Richard Marlink and Nir Eyal share insights on various countries’ approaches to the COVID-19 pandemic, as well as pandemic-related inequities both among and within countries.
Vaccine access amid political turmoil in Venezuela is the backdrop of institute director Richard Marlink’s comments, for a story published by Devex, about COVAX and a global response to the pandemic.
In an interview with The Daily Targum, institute director Richard Marlink explains the international collaboration to distribute COVID-19 vaccines more equitably worldwide.
